Equity-Based Compensation - Summary of Activity for Stock Option (Details) - USD ($) $ / shares in Units, $ in Thousands |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Share-Based Payment Arrangement [Abstract] | ||||
| Outstanding Options, Beginning Balance | 389 | 405 | 405 | |
| Outstanding Options, Forfeited | (1) | (1) | ||
| Outstanding Options, Ending Balance | 388 | 404 | 389 | 405 |
| Vested and exercisable | 388 | 342 | ||
| Weighted Average Exercise Price, Outstanding, Beginning Balance | $ 162.97 | $ 162.2 | $ 162.2 | |
| Weighted Average Exercise Price, Forfeited | 143.4 | 143.4 | ||
| Weighted Average Exercise Price, Outstanding, Ending Balance | 163.02 | 162.2 | $ 162.97 | $ 162.2 |
| Weighted Average Exercise Price, Vested and exercisable | $ 163.02 | $ 157 | ||
| Weighted average, term | 6 years 1 month 6 days | 7 years 2 months 12 days | 6 years 7 months 6 days | 7 years 8 months 12 days |
| Aggregate Intrinsic Value, Outstanding | $ 0 | $ 0 | $ 0 | $ 0 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|